These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16800628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
    Rao US.
    Biochemistry; 1998 Oct 20; 37(42):14981-8. PubMed ID: 9778376
    [Abstract] [Full Text] [Related]

  • 5. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N, Moitra K, Silver C, Ghosh P, Chattopadhyay A, Dey S.
    Biochemistry; 2006 Feb 28; 45(8):2739-51. PubMed ID: 16489767
    [Abstract] [Full Text] [Related]

  • 6. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM.
    Biochemistry; 1998 Sep 29; 37(39):13660-73. PubMed ID: 9753453
    [Abstract] [Full Text] [Related]

  • 7. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
    Liu R, Sharom FJ.
    Biochemistry; 1996 Sep 10; 35(36):11865-73. PubMed ID: 8794769
    [Abstract] [Full Text] [Related]

  • 8. P glycoprotein and the mechanism of multidrug resistance.
    Váradi A, Szakács G, Bakos E, Sarkadi B.
    Novartis Found Symp; 2002 Sep 10; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
    [Abstract] [Full Text] [Related]

  • 9. Catalytic mechanism of P-glycoprotein.
    Senior AE.
    Acta Physiol Scand Suppl; 1998 Aug 10; 643():213-8. PubMed ID: 9789563
    [Abstract] [Full Text] [Related]

  • 10. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
    Qu Q, Russell PL, Sharom FJ.
    Biochemistry; 2003 Feb 04; 42(4):1170-7. PubMed ID: 12549939
    [Abstract] [Full Text] [Related]

  • 11. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
    Delannoy S, Urbatsch IL, Tombline G, Senior AE, Vogel PD.
    Biochemistry; 2005 Oct 25; 44(42):14010-9. PubMed ID: 16229490
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
    Liu R, Sharom FJ.
    Biochemistry; 1997 Mar 11; 36(10):2836-43. PubMed ID: 9062112
    [Abstract] [Full Text] [Related]

  • 13. The catalytic cycle of P-glycoprotein.
    Senior AE, al-Shawi MK, Urbatsch IL.
    FEBS Lett; 1995 Dec 27; 377(3):285-9. PubMed ID: 8549739
    [Abstract] [Full Text] [Related]

  • 14. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
    Loo TW, Bartlett MC, Clarke DM.
    Biochemistry; 2004 Sep 28; 43(38):12081-9. PubMed ID: 15379547
    [Abstract] [Full Text] [Related]

  • 15. A cationic chalcogenoxanthylium photosensitizer effective in vitro in chemosensitive and multidrug-resistant cells.
    Holt JJ, Gannon MK, Tombline G, McCarty TA, Page PM, Bright FV, Detty MR.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8635-43. PubMed ID: 16945541
    [Abstract] [Full Text] [Related]

  • 16. Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy.
    Sauna ZE, Andrus MB, Turner TM, Ambudkar SV.
    Biochemistry; 2004 Mar 02; 43(8):2262-71. PubMed ID: 14979722
    [Abstract] [Full Text] [Related]

  • 17. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
    Sauna ZE, Smith MM, Muller M, Ambudkar SV.
    J Biol Chem; 2001 Jun 15; 276(24):21199-208. PubMed ID: 11287418
    [Abstract] [Full Text] [Related]

  • 18. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
    Loo TW, Bartlett MC, Clarke DM.
    Biochemistry; 2005 Aug 02; 44(30):10250-8. PubMed ID: 16042402
    [Abstract] [Full Text] [Related]

  • 19. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD, Sharom FJ.
    Biochemistry; 2008 Dec 23; 47(51):13686-98. PubMed ID: 19049391
    [Abstract] [Full Text] [Related]

  • 20. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.
    Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.